Forum topic

1 post / 0 new
WOCOVA 2012 Amsterdam June 2012


World Congress of Vascular Access

Amsterdam, Netherlands

Wednesday, 27 June – Friday, 29 June 2012 [email protected]

Beurs van Berlage, Amsterdam, the Netherlands (


Companies in the field of vascular access are invited to display their products at the industrial exhibition which will form part of the congress.

Satellite symposia will be organized by our sponsors during breakfast and dinner sessions

The Second Announcement which will be available online in October 2011 and will include abstract, registration and hotel information

All details concerning hotel booking will be stated in the Second Announcement and on the website.

P.O.Box 675
3720 AR Bilthoven
The Netherlands
T: +31 6 12053880
[email protected]

skype us for free if you have a skype account, skypename: wocova
follow us on twitter


When and where is WoCoVA….?
WoCoVA is on 27, 28 and 29th of June 2012 in Amsterdam, the congress will be held in the Beurs van Berlage,  Conference Center in the heart of Amsterdam.


Who will be attending WoCoVA…?
WoCoVA is a multidisciplinary and multiprofessional event where all aspects of vascular access will be covered, so all health care professionals interested in the field of short term and long term venous access are warmly invited to attend.

Where can I stay……?
There is a wide variety of accommodation close to the conference center and the sparkling activities of the city center, on the hotel page of this website you can book your room from our selection of hotels.
 June is the perfect time to extend your stay in the Netherlands and visit the flower gardens, the famous painters or the beaches.

What are the prices for attending the conference….?
This is also depending on when you register for the conference, the sooner the better. As soon as you can start registering for the conference you will find all the details on the registration page.

How many attendees do you expect will come to WoCoVA….?
We expect around 800 attendees, so you can meet many different people from several countries in your profession, also a great way for some networking.

Dear friends,
Following the success of the 1st World Congress of Vascular Access in  2010, WoCoVA is proud to offer a 2nd World Congress in June, 2012,  again highlighting global vascular access issues, technology advances,   evidence-based practices and an opportunity to network with professionals around the world.
The foundation WoCoVA (World Congress on Vascular Access) would be pleased to welcome all health care professionals, interested in short and long term venous access, to attend the second World Congress on Vascular Access in Amsterdam, the Netherlands from 27-29 June 2012.
WoCoVA was established in 2009 as a foundation to create an independent platform to organize worldwide congresses on vascular access.
This multidisciplinary and multi-professional event will cover all aspects of vascular access: indications for the choice of the device, insertion techniques, tip location methods and prevention and management of all vascular access device (VAD) related complication like infection, thrombosis, occlusion, etc.
Discussion will focus on the issues of safety, cost effectiveness and efficiency in vascular access, as well as on the need for world-shared guidelines for the clinical practice.
Scientific and educational sessions hosted by the most important international experts will offer an exceptional occasion for updating knowledge in this field, share experiences and learn of future trends in the area of vascular access devices.
Amsterdam has excellent meeting facilities in the Beurs van Berlage and its central location in the hart of Amsterdam ensures easy access. A visit to Amsterdam will also be a memorable experience in a remarkable 17th century city center and a lively international cultural and artistic atmosphere, making it even more attractive for health care professionals and health care companies to participate.
We look forward to welcome you in Amsterdam.

The WoCoVA team






  • A patient oriented approach for choosing the most appropriate VAD.
  • Development and testing of new and existing materials for VAD.
  • The expanding role of PICCs in intra-hospital venous access
  • Which is the best VAD for home care and palliative care.
  • Peripheral VADs: short cannula, long cannula or midline?
  • Who needs a central venous port?
  • The choice of VAD in neonates and children.
  • PICC vs. tunneled catheters in HPN.
  • How to choose the best VAD for acute/chronic dialysis.
  • Past and future of intra-osseous access
  • CVC vs. PICC in the intensive care unit.



  • Ultrasound and vascular access in 2012.
  • US-guided central venipuncture, or ‘it is not just the jugular’.
  • US-guided peripheral venipuncture: not going back!
  • Nerve damage during PICC insertion.
  • Needle, guidewire, introducers: when the technology makes the difference.
  • Puncture-related complications in the ultrasound era.
  • US guidance for neonatal and pediatric venous access.
  • Near infrared technology imaging for peripheral veins.
  • Insertion checklist: a new challenge.
  • Legal consequences of ‘blind’ venipuncture.


  • The ideal tip position: still controversial?
  • The risks and costs of malpositions.
  • The EKG method in 2012: techniques, pitfalls, devices.
  • EKG vs. fluoroscopy: safety, accuracy, cost-effectiveness.
  • Current role of the tracking devices.
  • Which tip position after femoral access.
  • Echocardiography for checking tip position.
  • How the tip moves…


  • Prevention bundles, targeting zero: where are we.
  • The ideal management of the exit site: antisepsis, dressing, securement.
  • The CDC 2011, INS standards of practice 2011, RCN 2010 guidelines: is everything clear?
  • The role of technology in infection prevention.
  • Risk of VAD infection: the importance of the location of the exit site.
  • Coated/treated central catheters: state of the art.
  • Chlorhexidine in 2012.
  • Management of CRBSI and salvage of the VAD.
  • Current recommendations for antibiotic lock.
  • Accuracy and cost-effectiveness in diagnosis of CRBSI.


  • Do we still need heparin and when?
  • Old and new alternatives to heparin.
  • Flushing and locking the VADs: what do the guidelines recommend.
  • Disobstruction of occluded VADs.
  • Valved vs. non-valved VADs.
  • Power injectable polyurethane and lumen occlusion.
  • Prevention of lumen occlusion in neonates and children..
  • The role of needlefree connectors: negative vs. positive displacement.


  • PICC and thrombosis: fact and fiction.
  • Venous thrombosis: role of VAD materials and VAD design.
  • Current recommendations for prevention of CVC-related thrombosis.
  • Management of VAD-related venous thrombosis.
  • Fibrin sleeve: still a controversial issue
  • Power injectable polyurethane and thrombosis.
  • Sutureless devices in the prevention of thrombophlebitis.
  • The role of in line filters in the prevention of thrombosis.



  • The increasing relevance of training in the field of venous access.
  • Training courses for central VAD insertion in USA and Europe.
  • PICC insertion: standards for training – around the world.
  • Education for VAD maintenance: do we have standards?
  • Simulation: the most powerful tool for training.
  • Education and role of the PICC team.

Scientific sessions with top-level speakers, organized by the most important companies in the world of vascular access. Not simultaneous to main sessions.

Abstracts will be accepted on the topics of the seven main sessions and selected for oral presentation at the end end of each session.


Abstracts will be accepted on the topics of the seven main sessions and on any other topic relevant to the world of vascular access.
Discussion of each poster will be scheduled at the poster exhibition every day during lunchtime

Theoretical-practical courses with hands-on practice on simulators:



  • US guidance for central venipuncture.
  • US guidance for peripheral venipuncture
  • US guidance and NIR (near-infrared) guidance in pediatrics
  • EKG method for positioning the tip of VADs